Edition:
United States

People: Perrigo Company PLC (PRGO.N)

PRGO.N on New York Stock Exchange

44.16USD
12:17pm EDT
Change (% chg)

$0.29 (+0.66%)
Prev Close
$43.87
Open
$44.16
Day's High
$44.50
Day's Low
$43.48
Volume
127,412
Avg. Vol
354,602
52-wk High
$80.66
52-wk Low
$36.33

Dillard, James 

Mr. James E. Dillard is an Executive Vice President and Chief Scientific Officer at Perrigo Company Public Limited Company. Mr. Dillard joined Perrigo from Altria Group, Inc., where he served as Senior Vice President, Research, Development and Sciences and Chief Innovation Officer from January 2009 to May 2018. During his tenure with Altria Group, Mr. Dillard led the creation of the Regulatory Affairs function in 2009 and also served as Chief Innovation Officer for Altria Client Services and Senior Vice President of Research, Development & Regulatory Affairs for Altria Group. He held science and technology leadership roles with U.S. Smokeless Tobacco Company, an Altria Group Inc. operating company, from 2001 to 2009. Mr. Dillard worked for the U.S. Food and Drug Administration between 1987 and 2001 as Director of the Division of Cardiovascular and Respiratory Devices, as well as in various leadership roles in the Center for Devices and Radiological Health and the Office of Device Evaluation.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --